Vitamin C supplementation in very preterm infants: a randomised controlled trial.
OBJECTIVE
To determine whether regulating vitamin C (ascorbic acid: AA) intake to achieve higher or lower plasma concentrations was associated with improved clinical outcome.


METHODS
A double blind, randomised controlled trial.


METHODS
Neonatal intensive care unit at Christchurch Women's Hospital.


METHODS
Infants with birth weight <1500 g or gestation <32 weeks, admitted to the unit within 48 hours of birth.


METHODS
Infants were randomised to one of three protocols with regard to AA supplementation for the first 28 days of life: group LL received low supplementation throughout; group LH received low until day 10 and then high: group HH received high throughout.


METHODS
Primary outcome measures were oxygen requirement at 28 days and 36 weeks postmenstrual age, total days supplemental oxygen, and retinopathy of prematurity. AA concentrations were measured at study entry (day 2), and days 10, 21, and 28.


RESULTS
A total of 119 infants were enrolled over 24 months (mean gestation 28.4 weeks; birth weight 1161 g). Six infants died, and these had significantly higher AA concentrations before randomisation than surviving infants (116 micromol/l (95% confidence interval 90 to 142) v 51 micromol/l (45 to 58), p<0.0001). There were no significant differences in primary outcomes between the groups. However, the proportion of surviving infants with an oxygen requirement at 36 weeks postmenstrual age in group HH (19%) was half that in group LL (41%) (p=0.06).


CONCLUSIONS
In a randomised controlled trial, no significant benefits or harmful effects were associated with treatment allocation to higher or lower AA supplementation throughout the first 28 days of life.
Darlow
B A
BA
Department of Paediatrics, Christchurch School of Medicine and Health Sciences, PO Box 4345, Christchurch, New Zealand. brian.darlow@chmeds.ac.nz
Buss
H
H
McGill
F
F
Fletcher
L
L
Graham
P
P
Winterbourn
C C
CC
D001205:Ascorbic Acid / Q000008:administration & dosage* / Q000097:blood; D019587:Dietary Supplements; D004311:Double-Blind Method; D005865:Gestational Age; D006801:Humans; D007226:Infant Mortality; D007231:Infant, Newborn; D007234:Infant, Premature; D019102:Infant, Very Low Birth Weight; D010102:Oxygen Inhalation Therapy / Q000379:methods; D012121:Respiration, Artificial / Q000379:methods
D001205:Ascorbic Acid
J Biol Chem. 1997 Jun 20;272(25):15656-60
9188455
Clin Sci (Lond). 1996 Nov;91(5):633-8
8942403
Int J Vitam Nutr Res. 1997;67(5):321-8
9350473
Am J Perinatol. 1998 Feb;15(2):133-40
9514139
Nature. 1998 Apr 9;392(6676):559
9560150
Pediatr Res. 1998 Jun;43(6):719-26
9621979
FASEB J. 1999 Jun;13(9):1007-24
10336883
FEBS Lett. 1992 Jun 1;303(2-3):210-2
1376697
JPEN J Parenter Enteral Nutr. 1992 May-Jun;16(3):241-7
1501354
J Nutr Sci Vitaminol (Tokyo). 1992 Oct;38(5):511-5
1294710
Arch Dis Child Fetal Neonatal Ed. 1994 Jul;71(1):F40-4
8092870
J Pediatr. 1995 Jan;126(1):128-31
7815202
Free Radic Res. 1995 Jan;22(1):57-65
7889148
Pediatr Res. 1995 Mar;37(3):343-53
7784144
Arch Dis Child Fetal Neonatal Ed. 1995 May;72(3):F211-2
7796246
Free Radic Res. 1996 Nov;25(5):439-54
8902542
Acta Paediatr. 2001 Jul;90(7):813-5
11519987
Biochem Biophys Res Commun. 2001 Oct 19;288(1):245-51
11594780
Free Radic Res. 2003 Jan;37(1):51-8
12653217
Am J Clin Nutr. 1981 Sep;34(9):1706-11
7282597
Am J Dis Child. 1983 Oct;137(10):949-51
6613937
J Pediatr Gastroenterol Nutr. 1983 Nov;2(4):629-34
6685761
Pediatrics. 1986 Apr;77(4):530-8
3083396
Anal Biochem. 1987 Aug 15;165(1):102-7
3688424
Am J Clin Nutr. 1988 Nov;48(5):1324-42
3142247
Proc Natl Acad Sci U S A. 1989 Aug;86(16):6377-81
2762330
Pediatr Res. 1989 Jul;26(1):20-4
2771505
Aust N Z J Ophthalmol. 1990 Feb;18(1):41-6
2357356
Free Radic Biol Med. 1997;23(3):361-6
9214571